Lourdes Calvo Martinez

5PUBLICATIONS
48CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 26, 2025
FOXC1 Expression Predicts Capecitabine Efficacy in Patients with Triple-Negative Breast Cancer from the GEICAM_CIBOMA Trial.

Federico Rojo, Clive R Taylor, Carlos Barrios

|Aug 20, 2023
Foot health and quality of life in women with breast cancer undergoing chemotherapy: a cross-sectional study.

Raquel Veiga-Seijo, Sonia Pertega-Diaz, Maria Eva Perez-Lopez

|Sep 27, 2022
Palbociclib Rechallenge for Hormone Receptor-Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial.

Joan Albanell, José Manuel Pérez-García, Miguel Gil-Gil

|Jun 12, 2021
Correction to: Is there a correlation between HER2 gene amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2‑positive breast cancer?

Silvia Antolín, Lucía García-Caballero, Cristina Reboredo

|May 02, 2021
Is there a correlation between HER2 gene amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2-positive breast cancer?

Silvia Antolín, Lucía García-Caballero, Cristina Reboredo

Pageof 1

Frequent Collaborators

3 joint publications

Silvia Antolin Novoa

3 joint publications

Maria Eva Perez-Lopez

2 joint publications

Lucía García-Caballero

2 joint publications

Tomás García-Caballero